These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23440420)

  • 1. KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis.
    Wong-Baeza I; Ridley A; Shaw J; Hatano H; Rysnik O; McHugh K; Piper C; Brackenbridge S; Fernandes R; Chan A; Bowness P; Kollnberger S
    J Immunol; 2013 Apr; 190(7):3216-24. PubMed ID: 23440420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.
    Cauli A; Shaw J; Giles J; Hatano H; Rysnik O; Payeli S; McHugh K; Dessole G; Porru G; Desogus E; Fiedler S; Hölper S; Carette A; Blanco-Gelaz MA; Vacca A; Piga M; Ibba V; Garau P; La Nasa G; López-Larrea C; Mathieu A; Renner C; Bowness P; Kollnberger S
    Rheumatology (Oxford); 2013 Nov; 52(11):1952-62. PubMed ID: 23804219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biochemistry and immunology of non-canonical forms of HLA-B27.
    Shaw J; Hatano H; Kollnberger S
    Mol Immunol; 2014 Jan; 57(1):52-8. PubMed ID: 23910730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.
    Bowness P; Ridley A; Shaw J; Chan AT; Wong-Baeza I; Fleming M; Cummings F; McMichael A; Kollnberger S
    J Immunol; 2011 Feb; 186(4):2672-80. PubMed ID: 21248258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.
    Hatano H; Shaw J; Marquardt K; Zhang Z; Gauthier L; Chanteux S; Rossi B; Li D; Mitchell J; Kollnberger S
    J Immunol; 2015 Feb; 194(4):1591-601. PubMed ID: 25582852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.
    Giles J; Shaw J; Piper C; Wong-Baeza I; McHugh K; Ridley A; Li D; Lenart I; Antoniou AN; DiGleria K; Kuroki K; Maenaka K; Bowness P; Kollnberger S
    J Immunol; 2012 Jun; 188(12):6184-93. PubMed ID: 22593621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.
    Rysnik O; McHugh K; van Duivenvoorde L; van Tok M; Guggino G; Taurog J; Kollnberger S; Ciccia F; Baeten D; Bowness P
    J Autoimmun; 2016 Jun; 70():12-21. PubMed ID: 27036372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.
    Chen L; Ridley A; Hammitzsch A; Al-Mossawi MH; Bunting H; Georgiadis D; Chan A; Kollnberger S; Bowness P
    Ann Rheum Dis; 2016 May; 75(5):916-23. PubMed ID: 26130142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
    Kollnberger S; Chan A; Sun MY; Chen LY; Wright C; di Gleria K; McMichael A; Bowness P
    Eur J Immunol; 2007 May; 37(5):1313-22. PubMed ID: 17407096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.
    Ridley A; Hatano H; Wong-Baeza I; Shaw J; Matthews KK; Al-Mossawi H; Ladell K; Price DA; Bowness P; Kollnberger S
    Arthritis Rheumatol; 2016 Apr; 68(4):901-14. PubMed ID: 26841353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis.
    Chan AT; Kollnberger SD; Wedderburn LR; Bowness P
    Arthritis Rheum; 2005 Nov; 52(11):3586-95. PubMed ID: 16255049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIR3DL1 interaction with HLA-B27 is altered by ankylosing spondylitis associated ERAP1 and enhanced by MHC class I cross-linking.
    Abdullah H; Zhang Z; Yee K; Haroon N
    Discov Med; 2015; 20(108):79-89. PubMed ID: 26321090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis.
    Cauli A; Piga M; Dessole G; Porru G; Floris A; Vacca A; Desogus E; La Nasa G; Mathieu A
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S15-9. PubMed ID: 25381967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of human leucocyte antigen class I free heavy chains on monocytes of patients with spondyloarthritis and cells transfected with HLA-B27.
    Ding J; Feng Y; Zheng ZH; Li XY; Wu ZB; Zhu P
    Int J Immunogenet; 2015 Feb; 42(1):4-10. PubMed ID: 25545293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Position 97 of HLA-B, a residue implicated in pathogenesis of ankylosing spondylitis, plays a key role in cell surface free heavy chain expression.
    Chen L; Shi H; Yuan J; Bowness P
    Ann Rheum Dis; 2017 Mar; 76(3):593-601. PubMed ID: 27515058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis.
    Haroon N; Tsui FW; Uchanska-Ziegler B; Ziegler A; Inman RD
    Ann Rheum Dis; 2012 Apr; 71(4):589-95. PubMed ID: 22355039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of HLA-Class I Heavy-Chain Interactions with Killer-Cell Immunoglobulin-Like Receptors in Immune Regulation.
    Kollnberger S
    Crit Rev Immunol; 2016; 36(3):269-282. PubMed ID: 28008807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two new cases of KIR3DP1, KIR2DL4-negative genotypes, one of which is also lacking KIR3DL2.
    Niepiekło-Miniewska W; Zuk N; Dubis J; Kurpisz M; Senitzer D; Havrylyuk A; Grendziak R; Witkiewicz W; Chopyak V; Kuśnierczyk P
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):423-9. PubMed ID: 25033772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis.
    Kollnberger S; Bowness P
    Adv Exp Med Biol; 2009; 649():277-85. PubMed ID: 19731637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pas de quatre: an interaction of HLA-B*27:05 and KIR3DL2 homodimers in spondyloarthropathies.
    Kuśnierczyk P; Majorczyk E
    Rheumatology (Oxford); 2013 Nov; 52(11):1931-2. PubMed ID: 24049102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.